NZ187926A - 19-nor-pregnahexaenes anti-mitotic pharmaceutical compositions - Google Patents
19-nor-pregnahexaenes anti-mitotic pharmaceutical compositionsInfo
- Publication number
- NZ187926A NZ187926A NZ187926A NZ18792678A NZ187926A NZ 187926 A NZ187926 A NZ 187926A NZ 187926 A NZ187926 A NZ 187926A NZ 18792678 A NZ18792678 A NZ 18792678A NZ 187926 A NZ187926 A NZ 187926A
- Authority
- NZ
- New Zealand
- Prior art keywords
- pregnahexaenes
- mitotic
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
- 230000002927 anti-mitotic effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81918277A | 1977-07-26 | 1977-07-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ187926A true NZ187926A (en) | 1980-10-08 |
Family
ID=25227423
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ187926A NZ187926A (en) | 1977-07-26 | 1978-07-21 | 19-nor-pregnahexaenes anti-mitotic pharmaceutical compositions |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0000609B1 (en) |
| JP (1) | JPS5424864A (en) |
| AT (1) | ATA532778A (en) |
| AU (1) | AU518819B2 (en) |
| CA (1) | CA1118410A (en) |
| DE (1) | DE2861112D1 (en) |
| DK (1) | DK326478A (en) |
| FI (1) | FI782305A7 (en) |
| GR (1) | GR73119B (en) |
| NO (1) | NO782538L (en) |
| NZ (1) | NZ187926A (en) |
| PT (1) | PT68338A (en) |
| ZA (1) | ZA784081B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4897290A (en) * | 1986-09-26 | 1990-01-30 | Konishiroku Photo Industry Co., Ltd. | Method for manufacturing the substrate for liquid crystal display |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3410879A (en) * | 1967-04-12 | 1968-11-12 | American Home Prod | Process for preparing gonahexaenes |
-
1978
- 1978-07-18 ZA ZA00784081A patent/ZA784081B/en unknown
- 1978-07-20 DE DE7878200112T patent/DE2861112D1/en not_active Expired
- 1978-07-20 EP EP78200112A patent/EP0000609B1/en not_active Expired
- 1978-07-21 CA CA000307894A patent/CA1118410A/en not_active Expired
- 1978-07-21 AU AU38248/78A patent/AU518819B2/en not_active Expired
- 1978-07-21 PT PT68338A patent/PT68338A/en unknown
- 1978-07-21 FI FI782305A patent/FI782305A7/en unknown
- 1978-07-21 DK DK326478A patent/DK326478A/en not_active Application Discontinuation
- 1978-07-21 GR GR56836A patent/GR73119B/el unknown
- 1978-07-21 AT AT0532778A patent/ATA532778A/en not_active Application Discontinuation
- 1978-07-21 NZ NZ187926A patent/NZ187926A/en unknown
- 1978-07-24 JP JP9031978A patent/JPS5424864A/en active Pending
- 1978-07-24 NO NO782538A patent/NO782538L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK326478A (en) | 1979-01-27 |
| GR73119B (en) | 1984-02-03 |
| ATA532778A (en) | 1982-12-15 |
| JPS5424864A (en) | 1979-02-24 |
| PT68338A (en) | 1978-08-01 |
| DE2861112D1 (en) | 1981-12-10 |
| AU518819B2 (en) | 1981-10-22 |
| FI782305A7 (en) | 1979-01-27 |
| CA1118410A (en) | 1982-02-16 |
| NO782538L (en) | 1979-01-29 |
| ZA784081B (en) | 1979-07-25 |
| EP0000609B1 (en) | 1981-09-23 |
| AU3824878A (en) | 1980-01-24 |
| EP0000609A1 (en) | 1979-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA781398B (en) | Pharmaceutical compositions | |
| ZA785682B (en) | Pharmaceutical compositions | |
| GB2003028B (en) | Pharmaceutical compositions | |
| JPS53109934A (en) | Pharmaceutical composition | |
| JPS5484022A (en) | Pharmaceutical composition | |
| JPS5449333A (en) | Pharmaceutical composition | |
| JPS53133637A (en) | Pharmaceutical composition | |
| PH15193A (en) | Pharmaceutical composition | |
| GB2008403B (en) | Pharmaceutical compositions | |
| GB2021409B (en) | Pharmaceutical composition | |
| GB2002229B (en) | Pharmaceutical composition | |
| MW478A1 (en) | Pharmaceutical compositions | |
| ZA784470B (en) | Pharmaceutical compositions including antithormbotic compositions | |
| JPS5394038A (en) | Pharmaceutical composition | |
| IL54220A0 (en) | Pharmaceutical compositions comprising trans-broparestrol | |
| NZ186334A (en) | Oxadiazolopyrimidines:pharmaceutical compositions | |
| ZA78387B (en) | Pharmaceutical compositions | |
| GB2008408B (en) | Pharmaceutical compositions | |
| ZA7812B (en) | Pharmaceutical compositions | |
| JPS545045A (en) | Pharmaceutical composition | |
| GB1556851A (en) | Pharmaceutical compositions | |
| ZA782736B (en) | Pharmaceutical compositions | |
| JPS542338A (en) | Pharmaceutical composition | |
| JPS5480427A (en) | Pharmaceutical composition having antiiviral property | |
| GB2006010B (en) | Pharmaceutical compositions |